Endocrine therapy reevaluated

Review OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Endocrine therapy shows benefit in amenorrhea, menopause, endometriosis, and breast cancer metastasis, but judicious use is critical for proven indications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endocrine therapy has produced dramatic results in some situations in obstetrics and gynecology and is beneficial in amenorrhea of unknown origin, in some menopausal patients, and in some cases of endometriosis. It also seems to retard progression of metastasis in patients who have had surgery or radiotherapy in breast cancer. Nevertheless, the physician must guard against using endocrine therapy injudiciously and limit it to only those conditions in which it is of proved benefit.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Genital Diseases, Female Gonadal Steroid Hormones Pregnancy Complications Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Threatened Abortion, Threatened Abortion, Threatened Adult Adult Aged Aged Age Factors Age Factors Aging Aging Amenorrhea Amenorrhea Amenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:57:48.939683+00:00
unpaywall
last seen: 2026-11-04T06:24:41.714486+00:00
License: CC0 · commercial use OK